Henry Schein, Inc.
$78.73
▼
-0.14%
2026-04-22 10:12:13
www.henryschein.com
NMS: HSIC
Explore Henry Schein, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.06 B
Current Price
$78.73
52W High / Low
$89.29 / $61.95
Stock P/E
24.1
Book Value
$28.03
Dividend Yield
—
ROCE
9.49%
ROE
8.7%
Face Value
—
EPS
$3.27
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Distribution
Employees
25,000
Beta
0.88
Debt / Equity
71.74
Current Ratio
1.38
Quick Ratio
0.76
Forward P/E
12.82
Price / Sales
0.66
Enterprise Value
$13.47 B
EV / EBITDA
13.17
EV / Revenue
1.02
Rating
Buy
Target Price
$89.23
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Empro Group Inc. | $17.36 | — | $144.63 M | — | 39.59% | 66.26% | $18.14 / $2.55 | $1.02 |
| 2. | Accendra Health, Inc. | $3.52 | — | $270.97 M | — | 14.74% | -1.64% | $9.55 / $1.84 | $-6.04 |
| 3. | Cosmos Health Inc. | $0.38 | — | $20.65 M | — | -53.42% | -63.82% | $1.32 / $0.28 | $0.73 |
| 4. | McKesson Corporation | $837.14 | 24.1 | $102.52 B | 0.38% | 35.58% | -162.92% | $999 / $637 | $-10.55 |
| 5. | Synergy CHC Corp. | $0.51 | — | $5.93 M | — | -93.25% | 62.08% | $4 / $0.42 | $-0.73 |
| 6. | Cencora, Inc. | $310.27 | — | $13.74 B | 0.73% | 20.96% | 1.33% | $377.54 / $271 | $9.81 |
| 7. | Cardinal Health, Inc. | $202.95 | 29.15 | $47.74 B | 0.95% | 16.32% | -52.09% | $233.6 / $129.52 | $-12.22 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 3.44 B | 3.34 B | 3.24 B | 3.17 B | 3.19 B |
| Operating Profit | 186 M | 198 M | 174 M | 200 M | 192 M |
| Net Profit | 101 M | 101 M | 86 M | 110 M | 94 M |
| EPS in Rs | 0.88 | 0.88 | 0.75 | 0.96 | 0.82 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 13.18 B | 12.67 B | 12.34 B | 12.65 B |
| Operating Profit | 758 M | 731 M | 695 M | 878 M |
| Net Profit | 398 M | 390 M | 416 M | 538 M |
| EPS in Rs | 3.47 | 3.4 | 3.63 | 4.69 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 11.21 B | 10.22 B | 10.57 B | 8.61 B |
| Total Liabilities | 6.42 B | 5.38 B | 5.42 B | 3.94 B |
| Equity | 3.25 B | 3.39 B | 3.65 B | 3.45 B |
| Current Assets | 4.46 B | 3.98 B | 4.49 B | 3.99 B |
| Current Liabilities | 3.23 B | 2.8 B | 2.68 B | 2.22 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 712 M | 848 M | 500 M | 602 M |
| Investing CF | -400 M | -430 M | -1.14 B | -276 M |
| Financing CF | -188 M | -510 M | 701 M | -315 M |
| Free CF | 521 M | 661 M | 313 M | 474 M |
| Capex | -191 M | -187 M | -187 M | -128 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 2.71% | -2.44% | — | — |
| Earnings Growth % | -6.25% | -22.68% | — | — |
| Profit Margin % | 3.08% | 3.37% | 4.25% | — |
| Operating Margin % | 5.77% | 5.63% | 6.94% | — |
| Gross Margin % | 31.69% | 31.28% | 30.29% | — |
| EBITDA Margin % | 7.2% | 6.9% | 7.51% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.